LRRK2 and Parkinson disease: Additionally, aspirin and ibuprofen have the potential to decrease the likelihood of LRRK2 mutations, indicating that anti-inflammatory medications could serve as beneficial treatments for modifying the progression of LRRK2-PD [252].